Showing results (501-510 of 611) with videos related to

Sort By:
Pageof 62
Gastroenterology|November 24, 2024
A Pangenotypic Hepatitis E Virus Replication Inhibitor With High Potency in a Rat Infection ModelXin Zhang, Mara Klöhn, Sivi Ouwerkerk-Mahadevan, et al.
Journal of Medicinal Chemistry|March 6, 2007
N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitorsThomas R Bailey, Susan R Rippin, Elizabeth Opsitnick, et al.
Antiviral Research|July 11, 2009
Identification of allosteric inhibitors blocking the hepatitis C virus polymerase NS5B in the RNA synthesis initiation stepStéphane Betzi, Cécilia Eydoux, Cécile Bussetta, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2008
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agentRoger G Ptak, Philippe A Gallay, Dirk Jochmans, et al.
European Journal of Medicinal Chemistry|December 9, 2014
New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2Dinesh Manvar, Sveva Pelliccia, Giuseppe La Regina, et al.
Journal of Medicinal Chemistry|September 30, 2022
Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main ProteaseMark S Cooper, Linlin Zhang, Mohamed Ibrahim, et al.
ACS Medicinal Chemistry Letters|May 16, 2022
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus ActivityMaria Giulia Nizi, Leentje Persoons, Angela Corona, et al.
Hepatology (Baltimore, Md.)|October 20, 2012
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral disseminationMuhammad N Zahid, Marine Turek, Fei Xiao, et al.
Pageof 62